Stay updated on Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial page.

Latest updates to the Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov study page remains a 403 Forbidden error page; its footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAccess to the study record now yields a 403 Forbidden page with a simple header and footer. The full study content is no longer shown, indicating restricted access rather than the previous detailed trial information.SummaryDifference18%

- Check48 days agoChange DetectedThe page now includes an NIH grant/contract identifier as part of the study's external identifiers, and the revision version has been updated to v3.6.6.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now includes new data-sharing details and links to additional trial documents, such as a Plain Language Trial Summary, IPD plan, and PDFs for the Study Protocol and Statistical Analysis Plan.SummaryDifference100%

- Check69 days agoChange DetectedThe page revision was updated to v3.6.5, signaling a new internal update to the study record.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing Revision: v3.6.3. This reflects a minor revision update to the listing's metadata.SummaryDifference0.0%

Stay in the know with updates to Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial page.